| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $485.4M | +29.4% |
| R&D Expense | $107.9M | +73.8% |
| SG&A Expense | $55.5M | +32.6% |
| Operating Income | $216.5M | +5.9% |
| Pre-tax Income | $239.1M | +9.1% |
| Income Tax | $80.6M | +22.7% |
| Net Income | $158.5M | +3.3% |
| EPS (Basic) | $0.56 | +0.0% |
| EPS (Diluted) | $0.50 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $386.5M | -18.8% |
| Current Assets | $1.03B | +10.3% |
| Total Assets | $1.54B | +16.9% |
| Current Liabilities | $118.3M | -2.0% |
| Total Liabilities | $307.6M | +5.1% |
| Stockholders' Equity | $1.23B | +20.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $277.4M | +13.4% |
| Capital Expenditures | $70.7M | +20.9% |
| Investing Cash Flow | -$352.6M | -6.1% |
| Financing Cash Flow | -$1.6M | +58.1% |
| Free Cash Flow | $206.7M | +11.1% |
| +4.2% |